Generic drugs can be a great way to save money, but a recent study shows there are risks involved.
As drug prices soar, consumers look for cheaper generics. A recent study showed safety issues in some generics made abroad, however, suggesting that the FDA's honor system may not be enough to ensure safety.
Michael Gove claims that drug prices are not on the negotiating table.
Could buying drugs from Canada be a solution to high prices for prescription drugs? It’s complicated.
Politicians and even HHS are now discussing ways to allow US consumers to buy drugs from Canada. Here's why it's not as simple as it seems.
A man looks at a prescription drug bottle. Many Americans will chronic conditions report rationing their drugs because of cost.
Presidential candidates and the current president have all talked about ways to lower drug costs, but experts know it is going to take more than politics to change how drugs are priced in the US.
Some biologics can cost up to a million dollars for a year’s worth.
Biologics, therapies made inside or of living cells, are a growing share of pharmaceutical sales. But the cost of these miracle treatments makes them unaffordable for many. New FDA guidance may help.
Sen. Chuck Grassley, R-Iowa, chair of the Senate Finance Committee, prepares for the Feb. 26, 2019 hearing with CEOs from several U.S. drug makers.
Pablo Martinez Monsivais/AP Photo
As concern grows for the escalating prices of prescription drugs, a novel approach to lower the price of drugs to treat hepatitis C in Louisiana holds promise, a policy expert says.
Policymakers and consumers are well aware of rising pharmaceuticals prices.
AP Photo/Elise Amendola
The Trump administration's proposal to lower drug prices focuses on discounts. A health policy scholar argues that the US could learn from Europe's system of measuring drug value and effectiveness.
President Donald Trump releases a ‘blueprint’ to reduce prescription drug prices, with Health and Human Services Secretary Alex Azar, in the Rose Garden of the White House in Washington, May 11, 2018.
(AP Photo/Carolyn Kaster)
The logic behind U.S. president Donald Trump's proposal that Canada and other countries have been “free-riding” off high prices in the United States is bizarre at best.
Heather Bresch, CEO of Mylan, holds two EpiPens as she testified before Congress Sept. 21, 2016 about rising costs of the drug.
AP Photo/Pablo Martinez Monsivais
The rising costs of generic drugs have led to outcries. In a search for solutions, four hospital systems are proposing to make drugs on their own. Could their idea work?
The cells inside this bioreactor are the real pharmaceutical factories.
Rather than being designed by chemists, this class of pharmaceuticals is produced by living cells. Here's where they come from and how they work.
New Zealand shows up Australia as badly in the field of pharmaceuticals as it does on the rugby field.
Drug prices in Australia are three times higher than in New Zealand. A key reason is the lack of transparency about taxpayer subsidies for Big Pharma and the companies' own finances.
Some of the notable additions to the PBS include drugs to treat eye and HIV infections, cystic fibrosis, multiple sclerosis, and cancer.
An independent expert provides his pick of the most notable drugs added to the PBS on May 1, 2017.
The FDA headquarters in Silver Spring, Maryland.
The Orphan Drug Act was enacted 34 years ago to encourage the development of drugs for rare diseases. Drug companies were guaranteed seven years of exclusivity. Then the rush was on to run up prices.
The government is paying too much for pharmaceuticals that are no better than their cheaper counterparts. Let’s fix that.
Australia is spending more than A$500 million a year too much for pharmaceuticals because of a little known loophole that allows drug companies to overcharge the government.
The rising costs of EpiPens has led to outrage.
The rising cost of drugs is more worrisome to most Americans than problems with Obamacare. Could proposals in California and Ohio help?
Taking off the label to charge more.
Pills by Shutterstock
Pharmaceutical companies aim to make a profit, but it took an industry insider to blow the whistle on some exorbitant drug costs the NHS was paying.
Bashing drugmakers can be an easy way to score political points.
Clinton, who named drug companies among her enemies in this week's debate, is pushing populist-inspired policies that could hamper the flow of new medicines.
The PBAC must make tough decisions about which cancer drugs to subsidise.
Most of us would agree that cancer drugs should be listed on the PBS, no matter how dear. But our health system can't afford all of them. How then are decisions about which drugs to subsidise made?
Trade minister Andrew Robb attends negotiations for the Trans Pacific Partnership in Sydney last year.
Dan Himbrechts/AAP Image
Over the next few weeks, the trade minister will be under intense pressure to renege on the government’s commitment to reject anything in the Trans Pacific Partnership that could undermine the PBS.
A group of oncologists have called on cancer patients to challenge the high prices charged by pharmaceutical companies for new cancer drugs.
Hope, fear, and desperation, along with the unique characteristics of the cancer drug market, create a “perfect storm” that continues to drive up prices for cancer drugs.